<code id='569573656F'></code><style id='569573656F'></style>
    • <acronym id='569573656F'></acronym>
      <center id='569573656F'><center id='569573656F'><tfoot id='569573656F'></tfoot></center><abbr id='569573656F'><dir id='569573656F'><tfoot id='569573656F'></tfoot><noframes id='569573656F'>

    • <optgroup id='569573656F'><strike id='569573656F'><sup id='569573656F'></sup></strike><code id='569573656F'></code></optgroup>
        1. <b id='569573656F'><label id='569573656F'><select id='569573656F'><dt id='569573656F'><span id='569573656F'></span></dt></select></label></b><u id='569573656F'></u>
          <i id='569573656F'><strike id='569573656F'><tt id='569573656F'><pre id='569573656F'></pre></tt></strike></i>

          leisure time

          leisure time

          author:entertainment    Page View:28814
          JUUL store sign -- health coverage from STAT
          Stephanie Keith/Getty Images

          Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

          Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

          advertisement

          It’s not clear how much the company ultimately spent on the partnerships.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Europe sees delivery challenges ahead on Alzheimer's therapies
          Europe sees delivery challenges ahead on Alzheimer's therapies

          VialsandpackagingforLeqembi,anewAlzheimer'smedicationapprovedintheU.S.,butnotyetinEurope.Illustratio

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Eli Lilly to acquire Versanis in heated race for weight loss drugs

          DarronCummings/APEliLillysaidFridayitwillacquireVersanisBio,aprivatecompanydevelopinganobesitydrugth